Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease

Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease

Huntington's disease (HD) is an inherited progressive neurodegenerative disorder resulting from CAG repeat expansion in the gene that encodes for the protein huntingtin. To identify neuroprotective compound (s) that can slow down disease progression and can be administered long term with few si...

Full description

Bibliographic Details
Main Authors:	Wenzhen Duan, Qi Peng, Naoki Masuda, Eric Ford, Erik Tryggestad, Bruce Ladenheim, Ming Zhao, Jean Lud Cadet, John Wong, Christopher A. Ross
Format:	Article
Language:	English
Published:	Elsevier 2008-06-01
Series:	Neurobiology of Disease
Subjects:	SSRI Serotonin BDNF Huntington's disease Neurogenesis
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996108000259

Similar Items

Mood disorders in Huntington’s disease: from behavior to cellular and molecular mechanisms
by: Patrick ePla, et al.
Published: (2014-04-01)

Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease
by: Naoki Masuda, et al.
Published: (2008-06-01)

Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington's disease
by: M.L. Choi, et al.
Published: (2014-06-01)

Altered selenium status in Huntington's disease: Neuroprotection by selenite in the N171-82Q mouse model
by: Zhen Lu, et al.
Published: (2014-11-01)

Differential Effects of Sertraline in a Predator Exposure Animal Model of Post-Traumatic Stress Disorder
by: C. Brad eWilson, et al.
Published: (2014-07-01)

Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease
by: Myoung-Hwa Lee, et al.
Published: (2011-03-01)

Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease
by: Jessica M. Simpson, et al.
Published: (2011-02-01)

Impairment and Restoration of Homeostatic Plasticity in Cultured Cortical Neurons From a Mouse Model of Huntington Disease
by: Amy I. Smith-Dijak, et al.
Published: (2019-05-01)

Sertraline and Alprazolam in the Treatment of Panic Disorder
by: Saida Fišeković, et al.
Published: (2005-05-01)

A tale of two maladies? Pathogenesis of depression with and without the Huntington’s disease gene mutation
by: Xin eDu, et al.
Published: (2013-07-01)

Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease
by: Qian Ma, et al.
Published: (2015-10-01)

Reactive Neuroblastosis in Huntington’s Disease: A Putative Therapeutic Target for Striatal Regeneration in the Adult Brain
by: Mahesh Kandasamy, et al.
Published: (2018-03-01)

Actions of Brain-Derived Neurotrophic Factor and Glucocorticoid Stress in Neurogenesis
by: Tadahiro Numakawa, et al.
Published: (2017-11-01)

Serotonin Syndrome Due to Overdose Intake of SSRI
by: Yavuz Orak, et al.
Published: (2015-08-01)

Title: Sex differences in stress-induced social withdrawal: role of brain derived neurotrophic factor in the bed nucleus of the stria terminalis
by: Gian David Greenberg, et al.
Published: (2014-01-01)

Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation
by: Mariam B. Camacho, et al.
Published: (2017-12-01)

Corrigendum: In vivo Hippocampal Serotonin Dynamics in Male and Female Mice: Determining Effects of Acute Escitalopram Using Fast Scan Cyclic Voltammetry
by: Rachel A. Saylor, et al.
Published: (2019-07-01)

In vivo Hippocampal Serotonin Dynamics in Male and Female Mice: Determining Effects of Acute Escitalopram Using Fast Scan Cyclic Voltammetry
by: Rachel A. Saylor, et al.
Published: (2019-04-01)

An oxygen-rich atmosphere or systemic fluoxetine extend the time to respiratory arrest in a rat model of obstructive apnea
by: S. Mooney, et al.
Published: (2020-02-01)

The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease
by: J.G. Doria, et al.
Published: (2015-01-01)

No evidence of association between BDNF gene variants and age-at-onset of Huntington's disease
by: Emilio Di Maria, et al.
Published: (2006-11-01)

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease
by: Mahmoud A. Pouladi, et al.
Published: (2012-12-01)

Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients
by: Orestes Vicente Forlenza, et al.
Published: (2000-07-01)

Brain-derived neurotrophic factor does not influence age at neurologic onset of Huntington’s disease
by: Shotaro Kishikawa, et al.
Published: (2006-11-01)

Subjecting Dams to Early Life Stress and Perinatal Fluoxetine Treatment Differentially Alters Social Behavior in Young and Adult Rat Offspring
by: Danielle J. Houwing, et al.
Published: (2019-03-01)

The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on the offspring
by: Jocelien DA Olivier, et al.
Published: (2013-05-01)

Effects of Repeated Systemic Administration of Fluoxetine on Offensive Aggresion in Syrian Hamsters (Mesocricetus auratus)
by: Emerson, Alan
Published: (2017)

Impaired TrkB signaling underlies reduced BDNF-mediated trophic support of striatal neurons in the R6/2 mouse model of Huntington’s Disease
by: Khanh Quoc Nguyen, et al.
Published: (2016-03-01)

The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease
by: Noel J. Buckley, et al.
Published: (2010-07-01)

Selective serotonin reuptake inhibitor (SSRI) antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved
by: Thibault eRenoir
Published: (2013-04-01)

Physiotherapy in Huntington’s disease
by: Hanne Ludt Fossmo, et al.
Published: (2013-01-01)

Juvenile Huntington disease in Argentina
by: Emilia Mabel Gatto, et al.
Published: (2015-01-01)

Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington’s Disease
by: Minhee Jang, et al.
Published: (2018-06-01)

MRI findings in juvenile Huntington's disease
by: Patrick Arraj, BS, et al.
Published: (2021-01-01)

GluN2B-containg NMDA receptors on adult-born granule cells contribute to the antidepressant action of fluoxetine
by: Lindsay eTannenholz, et al.
Published: (2016-05-01)

Implication de la huntingtine dans les troubles de l'humeur : approche comportementale et neurogénique
by: Orvoen, Sophie
Published: (2012)

Huntington’s disease: The Indian perspective
by: Srinivas Raju, et al.
Published: (2021-01-01)

Unawareness of deficits in Huntington's disease
by: McGlynn, Susan Mary, 1960-
Published: (1989)

The use of olanzapine in Huntington disease accompanied by psychotic symptoms
by: Cafer Alhan, et al.
Published: (2014-06-01)

Impact of a Histone Deacetylase Inhibitor—Trichostatin A on Neurogenesis after Hypoxia-Ischemia in Immature Rats
by: Teresa Zalewska, et al.
Published: (2020-05-01)